Adrienne L. Graves - Oct 22, 2024 Form 4 Insider Report for Opus Genetics, Inc. (IRD)

Role
Director
Signature
/s/ Amy Rabourn, by Power of Attorney
Stock symbol
IRD
Transactions as of
Oct 22, 2024
Transactions value $
$0
Form type
4
Date filed
10/24/2024, 05:59 PM
Previous filing
Jul 26, 2024
Next filing
May 2, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRD Stock Option (right to buy) Award $0 +173K $0.00 173K Oct 22, 2024 Common Stock 173K $1.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in a series of three equal annual installments over the three-year period measured from the grant date of October 22, 2024, subject to the Reporting Person's continuing service.